Table 3 Treatment outcomes of 200 adult... | American Society of Hematology

Table 3

Treatment outcomes of 200 adult non-L3 ALL patients by age

Age, y	No.	Complete remission		Resistant disease		Overall survival at 5 y*		Relapse-free survival at 5 y†		Disease-free survival at 5 y‡
Age, y	No.	%	95% CI, %	%	95% CI, %	Estimate	95% CI, %	Estimate	95% CI, %	Estimate	95% CI, %
15 to 29	86	87	78-93	3	1-10	39	27-49	32	21-43	48	31-65
30 to 49	71	80	69-89	14	7-24	32	21-43	29	17-41	40	23-58
50 to 65	43	63	47-77	19	8-33	23	11-36	22	7-38	25	4-46

Age, y	No.	Complete remission		Resistant disease		Overall survival at 5 y*		Relapse-free survival at 5 y†		Disease-free survival at 5 y‡
Age, y	No.	%	95% CI, %	%	95% CI, %	Estimate	95% CI, %	Estimate	95% CI, %	Estimate	95% CI, %
15 to 29	86	87	78-93	3	1-10	39	27-49	32	21-43	48	31-65
30 to 49	71	80	69-89	14	7-24	32	21-43	29	17-41	40	23-58
50 to 65	43	63	47-77	19	8-33	23	11-36	22	7-38	25	4-46

Five years after study entry.

Five years after complete remission.

Five years after start of maintenance chemotherapy (maintenance patients only).